HEALIUS LIMITED

0.56%

89.0¢

Market Cap $646.2M

Healthcare Medical Care

Healius Limited is a healthcare company. The Company’s specialized pathology businesses... Healius Limited is a healthcare company. The Company’s specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers its medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include QML, Laverty, Dorevitch, Western Diagnostic Pathology, TML, Agilex Biolabs, and Abbott Pathology, among others. These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia. It provides specialty diagnostic services to consumers and their referring practitioners.More

MEMPHASYS LIMITED

Many are concerned about global falling birthrates. This diverse stock has solutions. Here, then, one can’t afford to miss perusing what ASX-listed fertility tech healthcare smallcap Memphasys Ltd (ASX:MEM) can offer the world.

Latest Threads

Tag

Subject

HLS

Ann: Change of Director's Interest Notice - Kathy Ostin

10/11/25

170

10/11/25

Last post

ASX News

170

HLS

Ann: Notification regarding unquoted securities - HLS

10/11/25

128

10/11/25

Last post

ASX News

128

HLS

Ann: Becoming a substantial holder

04/11/25

476

04/11/25

Last post Mynodue

476

HLS

Ann: Appendix 3Y - Paul Anderson

04/11/25

349

04/11/25

Last post Mynodue

349

HLS

Ann: Change in substantial holding

04/11/25

328

04/11/25

Last post Mynodue

328

HLS

Ann: Becoming a substantial holder

04/11/25

5.9K

04/11/25

Last post CEOD

5.9K

HLS

Ann: 2025 AGM - Chair & CEO Addresses

30/10/25

643

30/10/25

Last post CEOD

643

HLS

Ann: Amended Constitution

30/10/25

117

30/10/25

Last post

ASX News

117

See All Discussions

Timeline

Change of Director's Interest Notice - Kathy Ostin
10 Nov 17:34	Share

Notification regarding unquoted securities - HLS
10 Nov 17:29	Share

Becoming a substantial holder
04 Nov 16:42	Share

Change in substantial holding
03 Nov 16:26	Share

Appendix 3Y - Paul Anderson
03 Nov 13:09	Share

Amended Constitution
30 Oct 13:54	Share

2025 AGM - Results of Meeting
30 Oct 13:45	Share

2025 AGM - Chair & CEO Addresses
30 Oct 10:17	Share

Appointment of Company Secretary
29 Oct 15:38	Share

Appointment of CFO & National Laboratory Operations Manager
08 Oct 08:23	Share

Becoming a substantial holder
02 Oct 18:32	Share

Becoming a substantial holder
01 Oct 10:11	Share

Becoming a substantial holder from CBA
30 Sep 14:46	Share

Final Director's Interest Notice - Neil Vinson
30 Sep 09:44	Share

Final Director's Interest Notice - Michael Stanford
30 Sep 09:42	Share

Initial Director's Interest Notice - Christopher Hall
30 Sep 09:35	Share

2025 Notice of Annual General Meeting
30 Sep 09:22	Share

Board Changes
30 Sep 09:09	Share

Appendix 4G - 2025
26 Sep 12:09	Share

2025 Corporate Governance Statement
26 Sep 12:08	Share

2025 Annual Report
26 Sep 12:08	Share

Change in substantial holding
10 Sep 15:20	Share

Notification of cessation of securities - HLS
05 Sep 17:04	Share

Ceasing to be a substantial holder
03 Sep 18:21	Share

Change in substantial holding
03 Sep 08:22	Share

Change in substantial holding
03 Sep 08:22	Share

Change of Director's Interest Notice - John Mattick
02 Sep 18:00	Share

Change of Director's Interest Notice - Kathy Ostin
02 Sep 17:54	Share

Change in substantial holding
01 Sep 17:29	Share

Change of Director's Interest Notice - Neil Vinson
01 Sep 16:11	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 89.0¢		Change -0.005(0.56%)		Mkt cap ! $646.2M

Open	High	Low	Value	Volume
89.0¢	90.0¢	87.5¢	$1.271M	1.431M

Buyers (Bids)

No.	Vol.	Price($)
5	1042	88.5¢

Sellers (Offers)

Price($)	Vol.	No.
89.0¢	971	2

View Market Depth

No.	Vol.	Price($)
1	448	0.885
1	3428	0.875
2	3150	0.870
3	8046	0.860
1	11059	0.855

Price($)	Vol.	No.
0.895	136806	1
0.900	15576	2
0.910	29030	4
0.915	20000	1
0.920	63833	7

Last trade - 16.10pm 14/11/2025 (20 minute delay)

HLS (ASX) Chart

HEALIUS LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

Healius selling Lumus to slash debt & return cash to investors

Healius is selling Lumus Imaging in a $965 million deal to pay down debt and 'return cash to shareholders'.

Healius (ASX:HLS) dealt blow as Takeovers Panel sees no issue with ACL’s (ASX:ACL) off-market bid

Healius (ASX:HLS) has been dealt a blow as the Takeovers Panel announced its decision against conducting proceedings over Australian Clinical Labs' (ACL) takeover bid last month.

Healius (ASX:HLS) reaffirms “no-action” stance regarding takeover proposal from ACL (ASX:ACL)

Last week, Australian Clinical Labs (ASX:ACL) made an off-market takeover bid to acquire Healius (ASX:HLS), but on Monday, Healius reaffirmed its direction to shareholders to take "no action" in relation to the offer.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News